(Reuters) - The U.S. Food and Drug Administration said it has approved a heart pump made by HeartWare International Inc's that supports blood flow in people with failing hearts who are awaiting a transplant. The company's shares rose 9.2 percent. HeartWare's left ventricular assist device, or LVAD, is designed to be implanted in the chest near the heart and used inside or outside the hospital ...
